PMC:7200337 / 76477-76680
Annnotations
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T864 | 64-65 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T34653 | 112-119 | Chemical | denotes | arbidol | http://purl.obolibrary.org/obo/CHEBI_134730 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2481 | 75-77 | Gene | denotes | to | Gene:6999 |
2487 | 51-59 | Species | denotes | patients | Tax:9606 |
2492 | 105-110 | Chemical | denotes | LPV/r | MESH:C558899 |
2493 | 112-119 | Chemical | denotes | arbidol | MESH:C086979 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T432 | 0-203 | Sentence | denotes | At day 14 of treatment, 76.2%, 62.4%, and 71.4% of patients had a positive to negative conversion in the LPV/r, arbidol, and control groups, respectively, with no statistical significance between groups. |